Buscar
cbdMD Inc
YCBDAñadir a la lista de seguimiento
0.509USD
+0.038+8.05%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
5.12MCap. mercado
0.02P/E TTM
Más Datos de cbdMD Inc Compañía
cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.
Información de cbdMD Inc
Símbolo de cotizaciónYCBD
Nombre de la empresacbdMD Inc
Fecha de salida a bolsaNov 17, 2017
Director ejecutivoKennedy (T. Ronan)
Número de empleados42
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 17
Dirección8845 Red Oak Blvd
CiudadCHARLOTTE
Bolsa de valoresNASDAQ OMX – NASDAQ Basic Amex
PaísUnited States of America
Código postal28217-5593
Teléfono17044453060
Sitio Webhttps://www.cbdmd.com/
Símbolo de cotizaciónYCBD
Fecha de salida a bolsaNov 17, 2017
Director ejecutivoKennedy (T. Ronan)
Ejecutivos de cbdMD Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Scott G. Stephen
Mr. Scott G. Stephen
Independent Chairman of the Board
Independent Chairman of the Board
3.41K
+46.14%
Mr. Bakari T. Sellers
Mr. Bakari T. Sellers
Independent Director
Independent Director
3.32K
+47.35%
Mr. William F. Raines, III
Mr. William F. Raines, III
Independent Director
Independent Director
--
--
Mr. T. Ronan Kennedy
Mr. T. Ronan Kennedy
Chief Executive Officer, Chief Financial Officer, Director
Chief Executive Officer, Chief Financial Officer, Director
--
--
Dr. Sibyl Swift
Dr. Sibyl Swift
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
--
--
Mr. Bradley Whitford
Mr. Bradley Whitford
Chief Accounting Officer, Treasurer, Company Secretary
Chief Accounting Officer, Treasurer, Company Secretary
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Scott G. Stephen
Mr. Scott G. Stephen
Independent Chairman of the Board
Independent Chairman of the Board
3.41K
+46.14%
Mr. Bakari T. Sellers
Mr. Bakari T. Sellers
Independent Director
Independent Director
3.32K
+47.35%
Mr. William F. Raines, III
Mr. William F. Raines, III
Independent Director
Independent Director
--
--
Mr. T. Ronan Kennedy
Mr. T. Ronan Kennedy
Chief Executive Officer, Chief Financial Officer, Director
Chief Executive Officer, Chief Financial Officer, Director
--
--
Dr. Sibyl Swift
Dr. Sibyl Swift
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
--
--
Mr. Bradley Whitford
Mr. Bradley Whitford
Chief Accounting Officer, Treasurer, Company Secretary
Chief Accounting Officer, Treasurer, Company Secretary
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de cbdMD Inc?
Los cinco principales accionistas de cbdMD Inc son: Mr. Scott G. Stephen
¿Cuál es la mayor fuente de ganancias de cbdMD Inc?
El 2026Q4, el segmento empresarial E-commerce sales generó la ganancia más alta para cbdMD Inc, ascendiendo a 3.60M y representando el 71.79% de la ganancia total.